Sylvie Grégoire

Non-Executive Director

Dr. Sylvie Grégoire is Executive Chair and Cofounder of EIP Pharma, a private company developing treatments for neurodegenerative diseases. Prior to this, she served as President of the Rare Disease division of Shire plc, a public biopharmaceutical company. Before that, Sylvie was CEO of GlycoFi, held executive positions at Biogen, Inc., and had clinical and regulatory roles at Merck & Co in Canada, Europe, and the United States.

Sylvie currently serves on the boards of Novo Nordisk and Perkin Elmer. She lends her experience for the benefit of health science companies based on her 30 years of experience in leadership positions with both public and private companies, as well as her current and past service on the boards of other public and private companies.

Scroll to Top